Van Dyke Thomas, Litkowski Leonard J, Kiersch Theodore A, Zarringhalam Nooshin Majd, Zheng Hongjie, Newman Kenneth
Goldman School of Dental Medicine, Boston University, 100 East Newton Street, Rm. 107, Boston, MA 02118, USA.
Clin Ther. 2004 Dec;26(12):2003-14. doi: 10.1016/j.clinthera.2004.12.002.
This study compared the efficacy and safety of a single dose of oxycodone 5 mg/ibuprofen 400 mg versus its individual components and placebo in a third-molar extraction model.
In this multicenter, double-blind, double-dummy, parallel-group investigation, subjects with moderate to severe pain within 5 hours after extraction of > or =2 ipsilateral bony impacted third molars were randomized to single doses of oxycodone 5 mg/ibuprofen 400 mg, ibuprofen 400 mg, oxycodone 5 mg, or placebo. Primary efficacy variables were the sum of pain intensity difference over 6 hours (SP1D6) and total pain relief through 6 hours (TOTPAR6). The pharmacokinetics of oxycodone and ibuprofen, alone and in combination, were also determined in a subset of patients.
A total of 498 subjects were randomized to treatment (187 to oxycodone 5 mg/ibuprofen 400 mg, 186 to ibuprofen 400 mg, 63 to oxycodone 5 mg, and 62 to placebo). Baseline demographics were generally similar among treatment groups, despite differences in sex (P = 0.041) and race (P = 0.023). Combination therapy was associated with greater analgesia than ibuprofen alone, oxycodone alone, or placebo (mean [SE] TOTPAR6: 13.3 [0.52], 12.2 [0.52], 4.3 [0.82], and 4.2 [0.83], respectively [P < 0.001 vs oxycodone or placebo, P = 0.012 vs ibuprofen]; mean [SE] SP1D6: 6.54 [0.42], 5.41 [0.44], 0.14 [0.60], and 0.32 [0.59], respectively [P < 0.001 vs oxycodone or placebo, P = 0.002 vs ibuprofen]). Combination therapy was well tolerated. Pharmacokinetic results implied no interaction between oxycodone and ibuprofen.
In this study, a single dose of oxycodone 5 mg/ibuprofen 400 mg was fast-acting, effective, and well tolerated in subjects with moderate to severe pain after dental surgery. Oxycodone 5 mg alone did not provide an efficacy benefit over placebo in this study.
本研究在第三磨牙拔除模型中比较了单剂量5毫克羟考酮/400毫克布洛芬与其单一成分及安慰剂的疗效和安全性。
在这项多中心、双盲、双模拟、平行组研究中,同侧≥2颗骨埋伏第三磨牙拔除后5小时内有中度至重度疼痛的受试者被随机分配接受单剂量5毫克羟考酮/400毫克布洛芬、400毫克布洛芬、5毫克羟考酮或安慰剂治疗。主要疗效变量为6小时内疼痛强度差值总和(SP1D6)以及6小时内的总疼痛缓解情况(TOTPAR6)。还在一部分患者中测定了羟考酮和布洛芬单独及联合使用时的药代动力学。
共有498名受试者被随机分配接受治疗(187人接受5毫克羟考酮/400毫克布洛芬治疗,186人接受400毫克布洛芬治疗,63人接受5毫克羟考酮治疗,62人接受安慰剂治疗)。尽管在性别(P = 0.041)和种族(P = 0.023)方面存在差异,但各治疗组的基线人口统计学特征总体相似。联合治疗比单独使用布洛芬、单独使用羟考酮或安慰剂具有更强的镇痛效果(平均[标准误]TOTPAR6分别为:13.3[0.52]、12.2[0.52]、4.3[0.82]和4.2[0.83][与羟考酮或安慰剂相比,P < 0.001;与布洛芬相比,P = 0.012];平均[标准误]SP1D6分别为:6.54[0.42]、5.41[0.44]、0.14[0.60]和0.32[0.59][与羟考酮或安慰剂相比,P < 0.001;与布洛芬相比,P = 照剂相比,P = 0.002])。联合治疗耐受性良好。药代动力学结果表明羟考酮和布洛芬之间无相互作用。
在本研究中,单剂量5毫克羟考酮/400毫克布洛芬对牙科手术后中度至重度疼痛的受试者起效迅速、有效且耐受性良好。在本研究中,单独使用5毫克羟考酮在疗效上并不优于安慰剂。